Inclusion criteria | |
Age | ≥ 18– ≤ 70 |
Sex | Male, female, or diverse |
Major depressive episode according to ICD-10 (F32.2–3, F33.2–3) | Single or recurrent episodes, as confirmed by the DIPS |
Symptom severity | Severe (MADRS ≥ 34) |
Modification in the therapeutic regimen is being considered | e.g., change of AD or change to neuromodulatory therapy |
First MDD episode < 50 years | |
Capacity for consent | |
Written informed consent | |
Exclusion criteria | |
Acute suicidality | |
Accommodation according to state law | (e.g., §16/17 Nds. PsychKG) |
Persistent depressive disorder (PDD) (ICD-10: F34.1) | |
(Lifetime) diagnoses of | Dementia, schizophrenia, schizoaffective disorder, bipolar disorder, substance addiction with currently necessary detoxification |
Simultaneous participation in other clinical trials that are not conducted within the scope of the P4D project |